Bioqube Ventures
Company: Bioqube Ventures
Description: Bioqube Ventures is a prominent investment firm specializing in the life sciences sector. Focused on advancing innovative therapeutic assets and technologies, the firm actively sources financing and develops ventures that have the potential to transform healthcare. By leveraging their extensive venture creation experience, Bioqube Ventures endeavors to translate and de-risk scientific innovations, thereby enhancing their investment portfolio and maximizing value for investors.
Founded in 2015 by Debora Dumont and Nico Vandervelpen, Bioqube Ventures was established with a clear mission to invest in groundbreaking therapeutics that hold the promise of significant impact. The firm took a notable step in 2016 when it launched its first investment vehicle on the Janssen campus in Beerse, further cementing its commitment to fostering innovation within the life sciences.
In 2020, Bioqube Ventures expanded its reach by launching its second investment vehicle, the Bioqube Factory Fund I (BFF I). This early-stage venture capital fund is dedicated to propelling exciting scientific advancements within vibrant European ecosystems, aimed at developing breakthrough therapies for patients. Bioqube Ventures employs a fit-for-purpose dual investment model, which not only includes traditional investments in initial funding rounds but also places a special emphasis on 'Create projects.' These projects necessitate additional de-risking efforts prior to forming new ventures, reflecting the firm's commitment to nurturing innovative ideas through all stages of development.
The team at Bioqube Ventures is composed of a diverse mix of fund managers, sector specialists, and serial entrepreneurs, all of whom possess a proven track record of successfully guiding companies along their growth trajectories. This hands-on approach ensures that each investment is not only well-supported but also strategically aligned with the broader goals of the firm.
The Bioqube Factory Fund I (BFF I) has garnered support from InnovFin Equity, which operates with the financial backing of the European Union under Horizon 2020 Financial Instruments, as well as the European Fund for Strategic Investments (EFSI), a component of the Investment Plan for Europe. The EFSI aims to facilitate productive investments across the European Union, thereby enhancing access to financing and supporting the implementation of significant projects. Through these initiatives and its focused investment strategy, Bioqube Ventures remains at the forefront of fostering innovation in the life sciences sector.
Industry: Venture Capital and Private Equity
Domain: http://www.bioqubeventures.com/
Founded: 2015
Location: Brussels
Address: Brussels, BE
Size: 2-10 employees
Direct Contacts
Name: Jon Edwards
Title: Managing Partner
Email: Direct Email
Company: Bioqube Ventures
LinkedIn: http://www.linkedin.com/in/edwardsjon
Phone: (781)-235-3060
Industry: Venture Capital and Private Equity
Location: San Diego, California